The Tokyo Biochemical Research Foundation (TBRF) and its Institute, the Tokyo Biochemical Research Institute were established in December, 1960, with the endowment from Chugai Pharmaceutical Co. Ltd., on the initiative of Juzo Ueno, the then president of the company, who responded to a proposal made by Morizo Ishidate, professor emeritus of the University of Tokyo, and several scientists responsible for medical and pharmaceutical research. The Institute performed biochemical studies on steroids, monosaccharides, polyamines, chemical carcinogens, and tumor immunology, which were highly evaluated and awarded prizes from several academic societies.
The Institute was closed in March, 1987, and since then TBRF has started to support a broad range of scientific programs. To enhance original research on pharmaceuticals most needed in Japan by conducting basic research on drug therapies and new drugs, TBRF engages in awarding grants for such research, and supporting education and research to foster promising young researchers in the fields of medical and pharmaceutical sciences in Japan.
The postdoctoral fellowships for Asian researchers in Japan were established in 1995 to foster and develop joint research with Japanese researchers by inviting promising and highly-qualified young researchers in Asian regions to host research institution in Japan for the purpose of contributing to the advancement of medical and pharmaceutical sciences both in Japan and Asia.
Research fields that contribute to creative research on pharmaceuticals in accordance with the articles of association of the TBRF.
Approximately 7 fellowships will be awarded for the 2017 fiscal year.
Full-time Japanese researchers (at position higher than lecturer and his/ her equivalent) affiliated with a Japanese university medical department, medical college, university pharmaceutical science department, pharmaceutical science college or other related research institutions.
It is advisable for host researchers to consult with the Foundation in advance.
The duration of the fellowship will generally be a minimum of 1 year which may be extended to a maximum of 2 years.
The candidate for the fellowship must maintain close contact with Japanese host researcher, and the host researcher should submit the following documents during the application acceptance period indicated below.
From August 1 to september 30, 2016
The screening committee of the TBRF will screen applications after which final decisions will be made by the Foundation's board of trustees.
Notification of screening results will be made in writing no later than December 25, 2016.
Accepted Asian fellows and host researchers will be announced in the foundationís internet home page and several Japanese medical and pharmaceutical journals.
It is generally preferred that successful candidates arrive in Japan no earlier than April, 2017 and no later than September, 2017.
Kyobashi NS Building, 2-5-21 Kyobashi, Chuo-ku, Tokyo
phone : +81-3-3562-5705 (overseas call)
fax : +81-3-3562-5730 (overseas call)
URL : http://www.tokyobrf.or.jp/